Skip to main content
. 2021 Apr 19;16:e14. doi: 10.15420/ecr.2020.52

Figure 3: Pharmacotherapeutic Options for Type 2 Diabetes Patients with HFrEF.

Figure 3:

*Based on evidence from DAPA-HF[40] and EMPEROR-Reduced.[55] CV = cardiovascular; HFrEF = heart failure with reduced ejection fraction; hHF = hospitalisation for heart failure; SGLT2 = sodium–glucose cotransporter 2; TZD = thiazolidinedione.